Palatable liquid solutions containing high concentrations of megranrude
The problems of bitter masking, stability and gastrointestinal side effects are addressed by using sodium benzoate, tartaric acid and glycerol/monoammonium glycyrrhizate mixture in Megroot liquid preparations, providing a high concentration, stable and palatable Megroot liquid preparation for use in patients with dysphagia.
Patent Information
- Application Number
- CN202380084161.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-10-07
- Filing Date
- 2023-10-09
- Publication Date
- 2025-07-29
AI Technical Summary
The existing Megrote preparations have problems with difficult to mask bitterness, risk of gastrointestinal side effects, poor stability and large volumes that are not suitable for patients with dysphagia, especially children, especially the concentration of liquid preparations and are not easy to preserve.
Use sodium benzoate as a preservative, tartaric acid adjusts the pH to 3 to 5, and a mixture of glycerin and monoammonium glycyrrhizate as a sweetener, avoid the use of carbohydrates, combine with acidic flavoring agents, and form a high concentration of Megrote liquid preparation, ensuring stable at room temperature for several months and good palatability.
It has achieved a high concentration of Megrote liquid preparation that is stable at room temperature for several months, has good palatability, and is suitable for patients with dysphagia, especially children, avoids gastrointestinal side effects, and is small in size and easy to swallow.